Veranex Acquires Fusion Biotec

Veranex (backed by Summit Partners) Forms Platform and Acquires Ximedica, Quartesian, and Boston Healthcare Associates

June 16, 2021

Healthcare Services

Veranex, formed in partnership with growth investor Summit Partners, launched a concept-to-commercialization medtech services platform and acquired three complementary companies: Ximedica, Quartesian, and Boston Healthcare Associates. The combined business brings design and engineering, clinical data, regulatory, and market-access/HEOR capabilities together to create an integrated, global medtech service provider.

Veranex Acquires Devicia, Clarvin and Affiliate Consultancies

October 11, 2022

Healthcare Services

Veranex, a global tech-enabled medtech service provider, acquired an ecosystem of Swedish medical device and IVD consultancies led by Devicia and Clarvin (including affiliates Kickfile, Lea Reg, and Limulus Bio). The add-on expands Veranex's regulatory, clinical, quality assurance, and biocompatibility capabilities and strengthens its European and UK presence to support MDR/IVDR strategies and local representation.

Veranex Acquires Medidee to Expand European MedTech Capabilities

September 20, 2022

Healthcare Services

Veranex has acquired Medidee, a Lausanne-based MedTech regulatory and clinical consultancy, expanding Veranex's footprint and capabilities across Europe, India and APAC. The deal strengthens Veranex’s regulatory affairs, clinical development, and quality assurance services for medical device and in vitro diagnostic clients; financial terms were not disclosed.

Veranex Acquires T3 Labs

December 13, 2023

Medical Devices

Veranex has acquired T3 Labs, a preclinical laboratory based in Atlanta, Georgia. The acquisition expands Veranex's preclinical footprint in North America and deepens its medical‑device testing and therapeutic expertise to provide more integrated services to medtech clients.

Accelmed Partners II and Lauxera Capital Invest in Veranex

November 14, 2022

Healthcare Services

Veranex has received strategic growth investments from Accelmed Partners II and Lauxera Capital Partners, joining existing investor Summit Partners, which retains majority ownership. The investments — terms undisclosed — will support Veranex’s continued global expansion and development of its integrated, tech‑enabled medical technology product development services; Uri Geiger (Accelmed) and Samuel Levy (Lauxera) joined Veranex’s board.

Anexinet and Veristor Merge to Create Verinext

January 17, 2023

IT Services

Anexinet Corporation, a Mill Point Capital portfolio company, merged with Veristor Systems to form Verinext, a combined full-service technology solutions provider. The merger expands geographic reach, engineering and managed-services capabilities and is backed by Mill Point Capital to accelerate growth and go-to-market scale.